Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011, 155(4):373-378 | DOI: 10.5507/bp.2011.067

HOSPITAL-ACQUIRED PNEUMONIA IN ICU PATIENTS

Radovan Uvizla, Vojtěch Hanulikb, Vendula Husickovab, Miroslava Htoutou Sedlakovab, Milan Adamusa, Milan Kolarb
a Department of Anesthesiology and Intensive Care Medicine, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic
b Department of Microbiology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital
Olomouc

Background: This prospective study aimed at assessing the effect of initial antibiotic therapy on the mortality of patients with hospital-acquired pneumonia (HAP) by analyzing bacterial pathogens and their resistance to antimicrobial agents.

Methods: Included were patients hospitalized in the Department of Anesthesiology and Intensive Care Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc and University Hospital Olomouc in 2009 who developed HAP. Bacterial pathogens and their resistance to antibiotics were identified using standard microbiological methods. The patient's mortality with respect to their initial antibiotic therapy was statistically analyzed.

Results: The group comprised 51 patients with HAP. Early-onset HAP was identified in 7 (14%) patients and late-onset HAP in 44 (86%) patients. The most frequent bacterial pathogens were strains of Klebsiella pneumoniae, Pseudomonas aeruginosa, Burkholderia cepacia complex and Escherichia coli, together accounting for 72%. Eighteen patients died directly due to HAP, an overall mortality rate of 35%. If initial therapy effective against the bacterial pathogen was selected, 21 patients survived and 9 died. If the bacterial pathogens were resistant to the selected initial antibiotic therapy, 9 patients died and 12 survived.

Conclusions: The mortality rates were 30% and 43% for adequate and inadequate antibiotic therapy, respectively. Given the small group of patients, the difference has low statistical significance. However, it does document the clinical impact of bacterial resistance on the survival or death of patients with HAP.

Keywords: Keywords: Hospital-acquired pneumonia, Bacterial pathogens, Resistance, Mortality

Received: July 15, 2011; Accepted: November 24, 2011; Prepublished online: December 19, 2011; Published: December 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Uvizl, R., Hanulik, V., Husickova, V., Htoutou Sedlakova, M., Adamus, M., & Kolar, M. (2011). HOSPITAL-ACQUIRED PNEUMONIA IN ICU PATIENTS. Biomedical papers155(4), 373-378. doi: 10.5507/bp.2011.067
Download citation

References

  1. Joseph NM, Sistla S, Dutta TK, Badhe AS, Parija SC. Ventilatorassociated pneumonia: A review. Eur J Intern Med 2010;21:360-8. Go to original source... Go to PubMed...
  2. Woodhead M, Blasi F, Ewig S, Huchon G, Leven M, Ortquist A, Schaberg T, Torres A, Van der Heijden G, Verheij TJM. ERS task force in collaboration with ESCMID. Guidelines for management of adult lower respiratory tract infections. Eur Respir J 2005;26:1138-80. Go to original source... Go to PubMed...
  3. Thomas M File. Epidemiology, pathogenesis, microbiology, and diagnosis of hospital-acquired, ventilator-associated, and healthcareassociated pneumonia in adults. UpToDate (2011) [cited 27 May 2011]. Available from: http://www.uptodate.com/home/index.html
  4. Luna CM, Vujacich P, Niederman MS, Vay C, Gherardi C, Matera J, Jolly EC. Impact of BAT data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997;111:676-85. Go to original source... Go to PubMed...
  5. Rello J, Torres A, Ricart M, Valles J, Gonzales J, Artigas A, Rodriques-Roisin R. Ventilator-associated pneumonia ba Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med 1994; 150:1545-9. Go to original source... Go to PubMed...
  6. European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 1.3, 5 January 2011 [cited 27 May 2011]. Available from: http://www.eucast.org/clinical_breakpoints
  7. Htoutou Sedlakova M, Hanulik V, Chroma M, Hricova K, Kolar M, Latal T, Schaumann R, Rodloff AC. Phenotypic detection of broad-spectrum beta-lactamases in microbiological practice. Med Sci Monit 2011;17:BR147-52. Go to original source... Go to PubMed...
  8. Pérez-Pérez FJ, Hanson ND. Detection of plasmid-mediated AmpC -lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002;40:2153-62. Go to original source... Go to PubMed...
  9. Pagani L, Dell'Amico E, Migliavacca R, D`Andrea MM, Giacobone E, Amicosante G, Romero E, Rossolini GM. Multiple CTX-M-type extended-spectrum -lactamases in nosocomial isolates of Enterobacteriaceae from a hospital in northern Italy. J Clin Microbiol 2003;41:4264-9. Go to original source... Go to PubMed...
  10. Oliveira DC, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002;46:2155-61. Go to original source... Go to PubMed...
  11. Shi ZY, Liu PYF, Lau YJ, Lin YH, Hu BS. Epidemiological typing of isolates from an outbreak of infection with multidrug-resistant Enterobacter cloacae by repetitive extragenic palindromic unit b1- primed PCR and pulsed-field gel electrophoresis. J Clin Microbiol 1996;34:2784-90. Go to original source... Go to PubMed...
  12. Vincent JL. Nosocomial pneumonia. Indian J Crit Care Med. 2001;5:14856.
  13. Drevinek P, Vosahlikova S, Cinek O, et al. Widespread clone of Burkholderia cenocepacia in cystic fibrosis patients in the Czech Republic. J Med Microbiol 2005;54:655-9. Go to original source... Go to PubMed...